Regulatory News
Tuesday, March 29, 2016
Keryx says anemia drug succeeds in study of kidney patients
March 29 (Reuters) - Keryx Biopharmaceuticals Inc
on Tuesday said its drug to treat iron deficiency anemia in
chronic kidney disease patients not yet requiring dialysis met
the goals of a late stage...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment